Fact CheckerSign in

NCT06798532Not yet recruiting

Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors

Source: ClinicalTrials.gov · Last updated 12 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Neuroblastic tumors (NBTs) develop from neural crest cells that give rise to the sympathetic nervous system. They include neuroblastomas, ganglioneuroblastomas, and ganglioneuromas. They represent approximately 10% of solid tumors in children under 15 years of age. In 15 to 20% of cases, NBTs are located in the thoracic region. These paravertebral tumors have an extracanal component and some also have an intraspinal component (dumbbell tumors) that can cause spinal cord compression. Surgery for these tumors also exposes the patient to neurological complications. In the thorax, the basi-thoracic location (T9-T12) may be particularly at risk due to the presence of the artery of Adamkiewicz (AKA), which supplies blood to the spinal cord; damage to this artery can result in spinal cord ischemia. To avoid this scenario, some teams recommend performing spinal cord arteriography to identify AKA. However, many centers do not perform arteriography and do not report more postoperative complications. Currently, there is no consensus on the indications for performing preoperative spinal arteriography in patients undergoing surgery for basi-thoracic NBT. This study evaluates the practice in France of preoperative arteriography to identify the AKA among patients undergoing surgery for basi-thoracic neuroblastic tumors and analyzes the incidence of postoperative neurological complications in these patients.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
150 (estimated)
First submitted
17 Jan 2025
Start date
Oct 2025
Primary completion date
Apr 2026
Lead sponsor
Assistance Publique - Hôpitaux de Paris
NCT number
NCT06798532

What you commit to

  • Study type: Observational
  • Planned participants: 150
  • From Oct 2025 to the primary completion date, Apr 2026
  • 27 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • 1\. Post-operative follow-up of less than 6 months

Who the study is looking for

  • Patients undergoing surgery for a neuroblastic tumor (neuroblastoma, ganglioneuroblastoma, ganglioneuroma)
  • Basithoracic location between T8 and L1
  • With or without intraspinal component
  • Treated in a pediatric surgery department in France
  • Between 2005 and 2024
  • Adult patients or holders of parental authority of minor patients informed and not opposed to the use of data for the study

Age in the registry: - to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (27)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU D'amiens
Coordinator of this site? Confirm its status
AmiensFranceUnknown status
CHU de Besançon
Coordinator of this site? Confirm its status
BesançonFranceUnknown status
CHU de Bordeaux
Coordinator of this site? Confirm its status
BordeauxFranceUnknown status
CHU de Brest
Coordinator of this site? Confirm its status
BrestFranceUnknown status
Chu de Lyon
Coordinator of this site? Confirm its status
BronFranceUnknown status
CHU de CAEN
Coordinator of this site? Confirm its status
CaenFranceUnknown status
CHU de DIJON
Coordinator of this site? Confirm its status
DijonFranceUnknown status
CHU de Grenoble
Coordinator of this site? Confirm its status
GrenobleFranceUnknown status
Hopital Bicetre
Coordinator of this site? Confirm its status
Le Kremlin-BicêtreFranceUnknown status
CHU de Lille
Coordinator of this site? Confirm its status
LilleFranceUnknown status
CHU de Limoges
Coordinator of this site? Confirm its status
LimogesFranceUnknown status
CHU de Marseille
Coordinator of this site? Confirm its status
MarseilleFranceUnknown status
CHU de Montpellier
Coordinator of this site? Confirm its status
MontpellierFranceUnknown status
CHU de Nancy
Coordinator of this site? Confirm its status
NancyFranceUnknown status
CHU Nantes
Coordinator of this site? Confirm its status
NantesFranceUnknown status
CHU Nice
Coordinator of this site? Confirm its status
NiceFranceUnknown status
Hôpital Trousseau
Coordinator of this site? Confirm its status
ParisFranceUnknown status
Hopital Robert Debre
Coordinator of this site? Confirm its status
ParisFranceUnknown status
Hopital Necker Enfants Malades
Coordinator of this site? Confirm its status
ParisFranceUnknown status
CHU de Poitiers
Coordinator of this site? Confirm its status
PoitiersFranceUnknown status
CHU de Reims
Coordinator of this site? Confirm its status
ReimsFranceUnknown status
CHU de Rennes
Coordinator of this site? Confirm its status
RennesFranceUnknown status
CHU de Rouen
Coordinator of this site? Confirm its status
RouenFranceUnknown status
CHU de la Réunion
Coordinator of this site? Confirm its status
Saint-DenisFranceUnknown status
CHU de Strasbourg
Coordinator of this site? Confirm its status
StrasbourgFranceUnknown status
CHU de Toulouse
Coordinator of this site? Confirm its status
ToulouseFranceUnknown status
CHU de Tours
Coordinator of this site? Confirm its status
ToursFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.